The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use this test to identify ...
Srinagar: Hundreds of patients suffering from respiratory illnesses are facing hardship due to the absence of advanced lung ...
The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...
ANDOVER, Mass.--(BUSINESS WIRE)--ndd Medical Technologies (ndd), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung ...
CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that ...
Among patients with a very early diagnosis of systemic sclerosis (VEDOSS), a baseline diffusing capacity of the lungs for carbon monoxide by single breath (DLCO/SB) below 70% was associated with a ...
Long-term survival and competing causes of death in men with stage I seminoma. Background: Lung function testing (LFT) during chemotherapy with bleomycin is controversial. We describe the impact of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results